Maternal Serum Screening Markers and Adverse Outcome: A New Perspective

by David Krantz, Terrence Hallahan, David Janik, Jonathan Carmichael
Published 2014-07-01

Development and Internal Validation of a Risk Prediction Model to Identify Myeloma Based on Routine Blood Tests: A Case-Control Study

by Lesley Smith, Jonathan Carmichael, Gordon Cook, Bethany Shinkins, Richard D. Neal
Published 2023-02-01

A comparison of peripheral blood stem cell collection outcomes for multiple myeloma; mobilization matters in the era of IMiD induction

by Thea Chandler, Christopher Parrish, Marina Karakantza, Jonathan Carmichael, David Pawson, Gordon Cook, Frances Seymour
Published 2023-08-01

Defining Unmet Need Following Lenalidomide Refractoriness: Real-World Evidence of Outcomes in Patients With Multiple Myeloma

by Catherine S. Y. Lecat, Catherine S. Y. Lecat, Jessica B. Taube, William Wilson, Jonathan Carmichael, Jonathan Carmichael, Christopher Parrish, Gabriel Wallis, Charalampia Kyriakou, Lydia Lee, Shameem Mahmood, Xenofon Papanikolaou, Neil K. Rabin, Jonathan Sive, Ashutosh D. Wechalekar, Kwee Yong, Gordon Cook, Gordon Cook, Rakesh Popat
Published 2021-07-01

Delayed diagnosis resulting in increased disease burden in multiple myeloma: the legacy of the COVID-19 pandemic

by Jonathan Carmichael, Frances Seymour, Graham McIlroy, Sarrah Tayabali, Rosie Amerikanou, Sylvia Feyler, Rakesh Popat, Guy Pratt, Christopher Parrish, A. John Ashcroft, Graham H. Jackson, Gordon Cook
Published 2023-03-01

P714: Genome screening of newborns: Sequencing is easy, assessing the clinical utility of genomic findings uncovered in asymptomatic children is challenging

by Jorune Balciuniene, Ruby Liu, Lora Bean, Babi Ramesh Reddy Nallamilli, Naga Guruju, Xiangwen Chen-Deutsch, Rizwan Yousaf, Kristina Fura, Eprem Chin, Abhinav Mathur, Zeqiang Ma, Jonathan Carmichael, Christin Collins, Cristina da Silva, Brian Kirmse, Steven Bleyl, Madhuri Hegde
Published 2024-01-01